We also evaluated their α-synuclein seeding activity via α-synuclein SAA (αSyn_SAA) and measured plasma levels of TDP-43 and neurofilament-light chain (NfL), aiming to explore their potential as biomarkers for ALS. The gene discussed is NEFL; the disease is amyotrophic lateral sclerosis.